Primary Audience

Click here to register for this event

Internal Medicine, Family Medicine, Primary Care

Topics

Vaccines

Activity Format

Enduring Material

Educational Objectives

Upon completion of this activity, participants should be better able to:

  1. Explain the epidemiology and burden of disease associated with HPV viruses
  2. Identify those HPV types most often associated with particular cancers and genital warts
  3. Discuss strategies to reduce the prevalence of these diseases

Faculty

Alexander.jpg

Kenneth A. Alexander, MD, PhD
Professor of Pediatrics
Cheif, Section of Pediatric Infectious Diseases
The University of Chicago
Chicago, IL

Giuliano.jpg

Anna R. Giuliano, PhD
Professor, Department of Oncologic Sciences
Chair, Department of Cancer Epidemiology
Program Leader, Cancer Epidemiology Program
H. Lee Moffitt Cancer Center & Research Institute
Tampa, FL

Educational Activity Agenda

HPV - Beyond Cervical Cancer

  • Dr. Alexander - Introduction, HPV: Facts and Figures
  • Dr. Giuliano - HPV Epidemiology and the Prevention of Cancer in Men and Women
  • Dr. Alexander - Male Immunization Cost-Benefit Analyses
  • Q&A
  • Post Test, Evaluation, and Credit Application

Release and Expiration Dates

Release Date: November 14, 2011
Expiration Date: November 14, 2012

Conflict of Interest Resolution

When faculty have reported Financial Relationships with one or more commercial interests, pmiCME works with the faculty to resolve such conflicts to ensure that the content presented is free of commercial bias and that it promotes improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.  The content of this presentation was vetted by the following mechanisms and modified as required to meet this standard:

--Content Peer Review by external topic Expert
--Content Validation by external topic Expert and internal pmiCME clinical editorial staff

Financial Disclosure Statements

It is the policy of pmiCME to ensure balance, independence, objectivity and scientific rigor in all its sponsored educational programs.  All faculty participating in the sponsored program are expected to disclose to the program audiences any real or apparent conflict(s) of interest related to the content of their presentation(s).

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

NAME TYPE COMMERCIAL SUPPORTERS
 Kenneth A. Alexander, MD, PhD Speaker & Advisor Honoraria Merck Vaccines
Advisor Honoraria GlaxoSmithKline
Principal Investigator Merck Vaccines
 Anna R. Giuliano, PhD
Consulting Fees Merck
Speaker Honoraria Merck

As a continuing medical education provider accredited by the ACCME, it is the policy of pmiCME to require any individual in a position to influence educational content to disclose the existence of any financial interest or other personal relationship with the manufacturer(s) of any commercial product(s).

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

pmiCME
PLANNER OR MANAGERFINANCIAL RELATIONSHIP
Alyce Kuklinski, NP
Nothing to disclose
 Kashemi Rorie, PhD  Nothing to disclose
Zachary Schwartz, MSc, ELS
Nothing to disclose

UNIVERSITY OF WISCONSIN
SCHOOL OF MEDICINE AND PUBLIC HEALTH
PLANNER OR MANAGERFINANCIAL RELATIONSHIP
 University of Wisconsin School of Medicine and Public Health Nothing to disclose

MILLER MEDICAL COMMUNICATIONS, LLC.
PLANNER OR MANAGERFINANCIAL RELATIONSHIP
 Lyerka Miller, PhD Nothing to disclose

Statement of Independence

pmiCME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. 

It is the mission of pmiCME to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve  patient outcomes.  To that end, we welcome your comments about how to better serve your needs.

Accreditation Statement

pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

pmiCME designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Obtain CME Credit

Attendees are expected to view all presentations before attempting to take the post test and complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credits™. To receive credit, the course must be completed between November 14, 2011 and November 14, 2012.

Participation in this program should be completed in approximately 2.0 hours. Please follow these steps in order to receive CME credit for participating in this program:

  • Read all of the CME accreditation information above.
  • Complete the online registration (registration is free).
  • View the complete educational activity.
  • Click on the link to apply for CME credit.
  • Complete the online post test and evaluation. Participants must receive a test score of at least 60% and answer all evaluation questions to receive a certificate.

After successfully completing the online post test and evaluation, your application will be immediately processed and you will be given the opportunity to download a personalized CME certificate for participation in this activity. 

Should you have any CME questions regarding this activity, please contact:

pmiCME
101 Huntington Avenue
Boston, MA 02199
Phone: 617-406-4000
Web: www.pmicme.org

 

Fee Information

There is no fee for this educational activity.

Investigational Disclosure

This presentation contains no mention of unapproved or investigational therapeutic agents.  pmiCME and this activity's commercial grantors do not recommend the use of any agent outside of the labeled indications.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, pmiCME, pmiCME Advisory Boards and Consultants, or Miller Medical Communications, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed.  Clinicians should review manufacturers' product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Policy on Privacy and Confidentiality

pmiCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. pmiCME and our educational partners will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

pmiCME and Miller Medical Communications, LLC. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Medium Used

This program has been made available online.
“HPV - Beyond Cervical Cancer"

System Requirements

To view the "Slides and Audio" version of this educational activity you will need a web broswer with Javascript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work.  To view the Video version of this educational activity Javascript and Microsoft Silverlight are required.

Commercial Support Statement

Merck__Co._Inc.png  This activity is supported by an educational grant from Merck.